Single-cell transcriptomics identifies ergothioneine as a mitochondrial protector to prevent AKI-to-CKD progression

Jiaxin Peng, Jing Chen, Zhipu Qian, Mingzhang Han, Ling Chen · 2026

Read Single-cell transcriptomics identifies ergothioneine as a mitochondrial protector to prevent AKI-to-CKD progression by Jiaxin Peng, Jing Chen, Zhipu Qian, Mingzhang Han, Ling Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351630.txt.

Description

Jiaxin Peng and colleagues tested a dietary compound, ergothioneine, as a shield for kidneys sliding from sudden injury toward chronic disease. That slide often follows chemotherapy drugs like cisplatin, which scar the kidney's tubules. In mice given cisplatin, the team combined tissue checks, blood tests, and single-cell gene reading to see what the compound changed.

Treated mice kept better kidney function and showed less scarring. Inside tubule cells, genes for the cell's power plants, which injury had scrambled, moved partway back toward normal. In dish-grown tubule cells, the compound cut damaging stress gases, preserved the power plants' charge, and kept energy levels up. The picture points at mitochondria as the compound's protective site, and suggests a food-derived molecule worth testing as kidney medicine.

Catalog record

CREATORJiaxin Peng, Jing Chen, Zhipu Qian, Mingzhang Han, Ling Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50879
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0351630

Browse the full library · About the Tower of Babel